IMUNON Advances IMNN-001 Phase 2 After Favorable Safety Review
LAWRENCEVILLE, N.J. — September 22, 2026 IMUNON announced that the Independent Data Monitoring Committee (IDMC) overseeing its Phase 2...
IL-12
Advertisement
IMUNON and NCI Advance IMNN-001 Clinical Development
LAWRENCEVILLE, N.J. — September 10, 2026 IMUNON, Inc. announced a Cooperative Research and Development Agreement (CRADA) with the National...
Lupin Wins FDA Approval for Modafinil Tablets in U.S.
Mumbai, India, and Naples, Florida, USA, September 4, 2026 Lupin Limited has received U.S. Food and Drug Administration (FDA)...
Samsung Bioepis Gains Japan Approval for Ustekinumab Biosimilar
Incheon, South Korea, September 3, 2026 Samsung Bioepis has announced that its ustekinumab biosimilar has received marketing approval in...
Gilead Wins FDA Approval for Bixlenvo HIV Single Tablet
FOSTER CITY, Calif. – August 27, 2026 Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA)...
Advertisements
Adicet Bio Gains FDA Clearance for ADI-212 IND in mCRPC
REDWOOD CITY, Calif. – August 27, 2026 Adicet Bio, Inc. announced that the U.S. Food and Drug Administration (FDA)...
RedHill Advances Opaganib for Emerging Ebola Outbreak
Tel Aviv, Israel & Raleigh, N.C., July 28, 2026 RedHill Biopharma Ltd. has announced significant progress in the emergency...
Philips Reports Strong Q2 2026 Growth and AI Innovation
Amsterdam, Netherlands, July 27, 2026 Royal Philips has reported solid second-quarter 2026 financial results, driven by 4% comparable sales...
InnoCare Phase III TYK2 Study Meets Psoriasis Endpoint
Beijing, July 27, 2026 InnoCare Pharma has announced that its novel TYK2 (Tyrosine Kinase 2) inhibitor fadeucravacitinib (ICP-488) successfully...
A2 Bio Reports First CAR-T Complete Response in Lung Cancer
CHICAGO, Illinois, 21 May 2026 A2 Biotherapeutics, Inc. announced new safety and efficacy results from its ongoing EVEREST-2 Phase...
Advertisement
